Losartan Potassium recall: Impurity Out of Spec
Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90
Why was Losartan Potassium recalled?
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: GS017651, Expiration 01/2020
- Product
- Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90
- Recalling firm
- Golden State Medical Supply Inc.
- Quantity
- 14,955 bottles (1,345,950 tablets)
- Distribution
- US Nationwide One (1) US government account. No foreign accounts.
- Recall date
- July 17, 2019
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)